Dosage and administration
Apply gel around nostrils and under nose as often as needed. Gel may be placed in nostrils to help relieve discomfort
Rhinase Soothing Nasal Gel
- Manufacturer
- Profounda Inc | Profounda, Inc
- Effective date
- 2021-01-11
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 23:36:44
Label at a glance#
ProductRhinase Soothing Nasal Gel
Label structure8 sections
Label contents#
Full prescribing information#
Warnings
- Use only as directed
- Keep this and all drugs out of reach of children
- The use of this dispensor by more than one person may spread infection
Inactive Ingredients
Purified water, Carbopol, Sodium Carboxymethylcellulose, Sodium Hydroxide, Benzalkonium Chloride
Rhinase Soothing Nasal Gel (Side Panel)
Moisturizer / Wetting Agent
Relieves dryness and irritation in and around the nose (nasal passages) caused by: dry room air, allergies, low humidity, chronic sinusitis, nose bleeds, stuffy nose, cold/flu, winter dryness, CPAP/BiPAP, Travel, Oxygen therapy
Adds moisture inside the nose to dissolve and soften thick, crusty mucus, making it easier to remove.
Warnings
Keep this and all drugs out of the reach of children
ACtive Ingredient
Polyethylene Glycol
Potassium Chloride
Propylene Glycol
Sodium Chloride
Directions
Apply gel around nostrils and under nose as often as needed. Gel may be placed in nostrils to help relieve discomfort
Indication and usage
Relieves dryness and irritation to and around the nose (nasal passages) caused by: dry room air, allergies,low humidity, chronic sinusitis, nose bleeds, stuffy nose, cold/flu, winter dryness, CPAP / BiPAP, travel, Oxygen therapy.
Adds moisture inside the nose to dissolve and soften thick, crusty mucus, making it easier to remove.
Rhinase Gel Carton
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69051-201-01 | 2023-01-30 | C162847 | 48780-1 | f386c649-af0e-0266-e053-dadaa90a7c1a | 2d90d16c-d9a8-2199-e054-00144ff8d46c |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69051-201-01 | Rhinase Soothing Nasal Gel | 30 g in 1 CARTON | GEL | 30 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69051-201-01 | GM - Gram | 69051-201 | 78ab7d8f-5745-45b0-b901-bdfabd852838 | 1 | 2017-04-05 |
Products#
Every source-derived product name is available through these pages.
- Rhinase Soothing Nasal Gel
- polyethylene glycol, potassium chloride, propylene glycol, sodium chloride
- POLYETHYLENE GLYCOL 3350
- DIPROPYLENE GLYCOL
- SODIUM CHLORIDE
- CARBOMER 934
- POTASSIUM CHLORIDE
- BENZALKONIUM CHLORIDE
- WATER
- CARBOXYMETHYLCELLULOSE SODIUM
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69051-201 | 69051-201-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INGR |
| DIPROPYLENE GLYCOL | E107L85C40 | INGR |
| SODIUM CHLORIDE | 451W47IQ8X | INGR |
| CARBOMER 934 | Z135WT9208 | INGR |
| POTASSIUM CHLORIDE | 660YQ98I10 | INGR |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INGR |
| WATER | 059QF0KO0R | INGR |
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INGR |
| SODIUM HYDROXIDE | 55X04QC32I | INGR |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b8a385a9-4bc6-ddac-e053-2995a90afae3 | 2d90d16c-d9a8-2199-e054-00144ff8d46c | 2021-01-11 | Warnings | b8a385a9-4bc6-ddac-e053-2995a90afae3 2d90d16c-d9a8-2199-e054-00144ff8d46c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.